You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR NATAMYCIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for natamycin

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00516399 ↗	A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine	Terminated	Los Angeles Biomedical Research Institute	Phase 3	2008-03-01	The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.
NCT00516399 ↗	A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine	Terminated	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Phase 3	2008-03-01	The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.
NCT00516399 ↗	A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine	Terminated	University of California, Los Angeles	Phase 3	2008-03-01	The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for natamycin

Condition Name

Chart
Table

Condition Name for natamycin
Intervention	Trials
Fungal Keratitis	4
Corneal Ulcer	3
Eye Infections, Fungal	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for natamycin
Intervention	Trials
Keratitis	5
Corneal Ulcer	4
Ulcer	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for natamycin

Trials by Country

Map
Table

Trials by Country for natamycin
Location	Trials
India	6
United States	4
Nepal	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for natamycin
Location	Trials
California	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for natamycin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for natamycin
Clinical Trial Phase	Trials
Phase 3	5
Phase 2/Phase 3	1
Phase 1/Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for natamycin
Clinical Trial Phase	Trials
Completed	4
Unknown status	1
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for natamycin

Sponsor Name

Chart
Table

Sponsor Name for natamycin
Sponsor	Trials
Aravind Eye Hospitals, India	4
University of California, San Francisco	4
Dartmouth-Hitchcock Medical Center	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for natamycin
Sponsor	Trials
Other	22
NIH	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.